1-11 of 11
James M. Gallo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2796: Predicting in vivo efficacy from in vitro data: Quantitative systems pharmacology modeling for an epigenetic modifier drug in cancer

Mehdi Bouhaddou, Li J. Yu, Serena Lunardi, Spyros K. Stamatelos, Fiona Mack, James M. Gallo, Marc R. Birtwistle, Antje-Christine Walz
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2796.
https://doi.org/10.1158/1538-7445.AM2018-2796
Published: 01 July 2018
View article titled, Abstract 2796: Predicting in vivo efficacy from in vitro data: Quantitative systems pharmacology modeling for an epigenetic modifier drug in cancer
Journal Articles

Intratumoral Modeling of Gefitinib Pharmacokinetics and Pharmacodynamics in an Orthotopic Mouse Model of Glioblastoma

Jyoti Sharma, Hua Lv, James M. Gallo
Journal: Cancer Research
Cancer Res (2013) 73 (16): 5242–5252.
https://doi.org/10.1158/0008-5472.CAN-13-0690
Published: 13 August 2013
View article titled, Intratumoral Modeling of Gefitinib Pharmacokinetics and Pharmacodynamics in an Orthotopic Mouse Model of Glioblastoma
Open the PDF for Intratumoral Modeling of Gefitinib Pharmacokinetics and Pharmacodynamics in an Orthotopic Mouse Model of Glioblastoma in another window
Includes: Supplementary data
Journal Articles

A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients

Lula Rosso, Cathryn S. Brock, James M. Gallo, Azeem Saleem, Patricia M. Price, Federico E. Turkheimer, Eric O. Aboagye
Journal: Cancer Research
Cancer Res (2009) 69 (1): 120–127.
https://doi.org/10.1158/0008-5472.CAN-08-2356
Published: 31 December 2008
View article titled, A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients
Open the PDF for A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients in another window
Journal Articles

Multidrug Resistance Protein 4 Protects Bone Marrow, Thymus, Spleen, and Intestine from Nucleotide Analogue–Induced Damage

Martin G. Belinsky, Ping Guo, Kun Lee, Feng Zhou, Elena Kotova, Alex Grinberg, Heiner Westphal, Irina Shchaveleva, Andres Klein-Szanto, James M. Gallo, Gary D. Kruh
Journal: Cancer Research
Cancer Res (2007) 67 (1): 262–268.
https://doi.org/10.1158/0008-5472.CAN-06-2680
Published: 08 January 2007
View article titled, Multidrug Resistance Protein 4 Protects Bone Marrow, Thymus, Spleen, and Intestine from Nucleotide Analogue–Induced Damage
Open the PDF for Multidrug Resistance Protein 4 Protects Bone Marrow, Thymus, Spleen, and Intestine from Nucleotide Analogue–Induced Damage in another window
Journal Articles

New endothelial cell system designed to deliver drugs by apoptosis.

Yasuhiro Mitsuuchi, Dennis R. Powell, Ping Guo, Feng Zhou, James M. Gallo
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 868.
Published: 01 April 2004
View article titled, New endothelial cell system designed to deliver drugs by apoptosis.
Journal Articles

The Effect of P-glycoprotein on Paclitaxel Brain and Brain Tumor Distribution in Mice

James M. Gallo, Shaolan Li, Ping Guo, Karin Reed, Jianguo Ma
Journal: Cancer Research
Cancer Res (2003) 63 (16): 5114–5117.
Published: 26 August 2003
View article titled, The Effect of P-glycoprotein on Paclitaxel Brain and Brain Tumor Distribution in Mice
Open the PDF for The Effect of P-glycoprotein on Paclitaxel Brain and Brain Tumor Distribution in Mice in another window
Journal Articles

Cells Designed to Deliver Anticancer Drugs by Apoptosis

Jianguo Ma, Karin A. Reed, James M. Gallo
Journal: Cancer Research
Cancer Res (2002) 62 (5): 1382–1387.
Published: 01 March 2002
View article titled, Cells Designed to Deliver Anticancer Drugs by Apoptosis
Open the PDF for Cells Designed to Deliver Anticancer Drugs by Apoptosis in another window
Journal Articles

Pharmacodynamic-mediated Reduction of Temozolomide Tumor Concentrations by the Angiogenesis Inhibitor TNP-470

Jianguo Ma, Sharon Pulfer, Shaolan Li, Jianxiong Chu, Karin Reed, James M. Gallo
Journal: Cancer Research
Cancer Res (2001) 61 (14): 5491–5498.
Published: 01 July 2001
View article titled, Pharmacodynamic-mediated Reduction of Temozolomide Tumor Concentrations by the Angiogenesis Inhibitor TNP-470
Open the PDF for Pharmacodynamic-mediated Reduction of Temozolomide Tumor Concentrations by the Angiogenesis Inhibitor TNP-470 in another window
Journal Articles

Correspondence re: A. S. Lübbe et al., Preclinical Experiences with Magnetic Drug Targeting: Tolerance and Efficacy. Cancer Res., 56: 4694–4701, 1996; and Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4′-Epidoxorubicin in 14 Patients with Advanced Solid Tumors. Cancer Res., 56: 4686–4693, 1996: Letter

James M. Gallo, Urs Hafeli
Journal: Cancer Research
Cancer Res (1997) 57 (14): 3063–3064.
Published: 01 July 1997
View article titled, Correspondence re: A. S. Lübbe <em>et al.</em>, Preclinical Experiences with Magnetic Drug Targeting: Tolerance and Efficacy. Cancer Res., <em>56:</em> 4694–4701, 1996; and Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4′-Epidoxorubicin in 14 Patients with Advanced Solid Tumors. Cancer Res., <em>56:</em> 4686–4693, 1996: <subtitle>Letter</subtitle>
Open the PDF for Correspondence re: A. S. Lübbe <em>et al.</em>, Preclinical Experiences with Magnetic Drug Targeting: Tolerance and Efficacy. Cancer Res., <em>56:</em> 4694–4701, 1996; and Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4′-Epidoxorubicin in 14 Patients with Advanced Solid Tumors. Cancer Res., <em>56:</em> 4686–4693, 1996: <subtitle>Letter</subtitle> in another window
Journal Articles

Uptake of Temozolomide in a Rat Glioma Model in the Presence and Absence of the Angiogenesis Inhibitor TNP-470

Damayanthi Devineni, Andres Klein-Szanto, James M. Gallo
Journal: Cancer Research
Cancer Res (1996) 56 (9): 1983–1987.
Published: 01 May 1996
View article titled, Uptake of Temozolomide in a Rat Glioma Model in the Presence and Absence of the Angiogenesis Inhibitor TNP-470
Open the PDF for Uptake of Temozolomide in a Rat Glioma Model in the Presence and Absence of the Angiogenesis Inhibitor TNP-470 in another window
Journal Articles

Time-dependent Pharmacodynamic Models in Cancer Chemotherapy: Population Pharmacodynamic Model for Glutathione Depletion following Modulation by Buthionine Sulfoximine (BSO) in a Phase I Trial of Melphalan and BSO

James M. Gallo, James Brennan, Thomas C. Hamilton, Theresa Halbherr, Paul B. Laub, Robert F. Ozois, Peter J. O'Dwyer
Journal: Cancer Research
Cancer Res (1995) 55 (20): 4507–4511.
Published: 01 October 1995
View article titled, Time-dependent Pharmacodynamic Models in Cancer Chemotherapy: Population Pharmacodynamic Model for Glutathione Depletion following Modulation by Buthionine Sulfoximine (BSO) in a Phase I Trial of Melphalan and BSO
Open the PDF for Time-dependent Pharmacodynamic Models in Cancer Chemotherapy: Population Pharmacodynamic Model for Glutathione Depletion following Modulation by Buthionine Sulfoximine (BSO) in a Phase I Trial of Melphalan and BSO in another window